GB201314577D0 - Intracellular immunity - Google Patents
Intracellular immunityInfo
- Publication number
- GB201314577D0 GB201314577D0 GB201314577A GB201314577A GB201314577D0 GB 201314577 D0 GB201314577 D0 GB 201314577D0 GB 201314577 A GB201314577 A GB 201314577A GB 201314577 A GB201314577 A GB 201314577A GB 201314577 D0 GB201314577 D0 GB 201314577D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- intracellular immunity
- immunity
- intracellular
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
- A61K47/6835—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
- A61K47/6839—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting material from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
- A61K47/6801—Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
- A61K47/6803—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB1314577.6A GB2517190A (en) | 2013-08-14 | 2013-08-14 | Intracellular immunity |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB1314577.6A GB2517190A (en) | 2013-08-14 | 2013-08-14 | Intracellular immunity |
Publications (2)
Publication Number | Publication Date |
---|---|
GB201314577D0 true GB201314577D0 (en) | 2013-09-25 |
GB2517190A GB2517190A (en) | 2015-02-18 |
Family
ID=49262177
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB1314577.6A Withdrawn GB2517190A (en) | 2013-08-14 | 2013-08-14 | Intracellular immunity |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB2517190A (en) |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5521291A (en) * | 1991-09-30 | 1996-05-28 | Boehringer Ingelheim International, Gmbh | Conjugates for introducing nucleic acid into higher eucaryotic cells |
US20100266620A1 (en) * | 2006-01-20 | 2010-10-21 | Le Sun | Immunoconjugates for treatment of infectious diseases |
GB201202268D0 (en) * | 2012-02-09 | 2012-03-28 | Medical Res Council | Intracellular immunity |
-
2013
- 2013-08-14 GB GB1314577.6A patent/GB2517190A/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
GB2517190A (en) | 2015-02-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1222846A1 (en) | Substituted benzylpyrazoles | |
HK1221717A1 (en) | Substituted benzylpyrazoles | |
GB201413149D0 (en) | No details | |
HRP20171890T1 (en) | Substituted imidazopyridazines | |
GB201410903D0 (en) | No details | |
HK1223362A1 (en) | Substituted pyrazolo-pyridinamines | |
GB201418212D0 (en) | No details | |
GB201418129D0 (en) | No details | |
PL3068827T3 (en) | Bitumenpolymerzusammensetzung mit verbesserten mechanischen kälteeigenschaften | |
GB201421548D0 (en) | No details | |
HK1220972A1 (en) | Substituted thiazolopyrimidines | |
IL246271A0 (en) | Substituted piperidinyl-tetrahydroquinolines | |
GB201408089D0 (en) | No details | |
GB201418214D0 (en) | No details | |
GB201416327D0 (en) | No details | |
GB201407200D0 (en) | No details | |
EP2975313A4 (en) | Fluid-throttling member | |
GB201417843D0 (en) | No details | |
PL2846091T3 (en) | Oxy-gas-brenner mit glühzündung | |
GB201321332D0 (en) | Fitting | |
GB201202268D0 (en) | Intracellular immunity | |
GB201314577D0 (en) | Intracellular immunity | |
GB201420267D0 (en) | No details | |
GB201420520D0 (en) | No details | |
GB201216568D0 (en) | Intracellular immunity |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WAP | Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1) |